Megakaryocytes are a Novel SARS-CoV-2 Infection Target and Risk Factor for Mortality and Multi-Organ Failure
Seth D. Fortmann, View ORCID ProfileMichael J. Patton, Blake F. Frey, Cristiano P. Vieira, Sivani B. Reddy, Forest Huls, Andrew Crouse, Jason Floyd, Ram Prasad, Vidya Sagar Hanumanthu, Sarah Sterrett, Jeremy D. Zucker, Peng Li, Nathan Erdmann, Paul A. Goepfert, Amit Gaggar, Maria B. Grant, View ORCID ProfileMatthew Might
doi: https://doi.org/10.1101/2021.08.05.21261552
Seth D. Fortmann
1Medical Scientist Training Program (MSTP), School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
3Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
Michael J. Patton
1Medical Scientist Training Program (MSTP), School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
2Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, Birmingham, AL, USA
Blake F. Frey
1Medical Scientist Training Program (MSTP), School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
4Department of Pathology, University of Alabama at Birmingham, Birmingham, AL
Cristiano P. Vieira
3Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
Sivani B. Reddy
6Department of Dermatology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
Forest Huls
2Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, Birmingham, AL, USA
Andrew Crouse
2Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, Birmingham, AL, USA
Jason Floyd
3Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
Ram Prasad
3Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
Vidya Sagar Hanumanthu
7Department of Medicine and Microbiology, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, USA
Sarah Sterrett
8Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA
Jeremy D. Zucker
5Pacific Northwest National Laboratories, Biological Sciences Division, Richland, WA, USA
Peng Li
9School of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA
Nathan Erdmann
8Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA
Paul A. Goepfert
8Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA
Amit Gaggar
12Department of Medicine, Division of Pulmonary, Allergy and Critical Care, University of Alabama at Birmingham, Birmingham, AL, USA
Maria B. Grant
3Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
Matthew Might
2Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, Birmingham, AL, USA
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted August 07, 2021.
Megakaryocytes are a Novel SARS-CoV-2 Infection Target and Risk Factor for Mortality and Multi-Organ Failure
Seth D. Fortmann, Michael J. Patton, Blake F. Frey, Cristiano P. Vieira, Sivani B. Reddy, Forest Huls, Andrew Crouse, Jason Floyd, Ram Prasad, Vidya Sagar Hanumanthu, Sarah Sterrett, Jeremy D. Zucker, Peng Li, Nathan Erdmann, Paul A. Goepfert, Amit Gaggar, Maria B. Grant, Matthew Might
medRxiv 2021.08.05.21261552; doi: https://doi.org/10.1101/2021.08.05.21261552
Megakaryocytes are a Novel SARS-CoV-2 Infection Target and Risk Factor for Mortality and Multi-Organ Failure
Seth D. Fortmann, Michael J. Patton, Blake F. Frey, Cristiano P. Vieira, Sivani B. Reddy, Forest Huls, Andrew Crouse, Jason Floyd, Ram Prasad, Vidya Sagar Hanumanthu, Sarah Sterrett, Jeremy D. Zucker, Peng Li, Nathan Erdmann, Paul A. Goepfert, Amit Gaggar, Maria B. Grant, Matthew Might
medRxiv 2021.08.05.21261552; doi: https://doi.org/10.1101/2021.08.05.21261552
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (671)
- Anesthesia (181)
- Cardiovascular Medicine (2656)
- Dermatology (224)
- Emergency Medicine (400)
- Epidemiology (12248)
- Forensic Medicine (10)
- Gastroenterology (763)
- Genetic and Genomic Medicine (4114)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2666)
- Health Policy (1005)
- Hematology (364)
- HIV/AIDS (853)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (439)
- Neurology (3897)
- Nursing (210)
- Nutrition (578)
- Oncology (2037)
- Ophthalmology (586)
- Orthopedics (241)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (452)
- Public and Global Health (6538)
- Radiology and Imaging (1407)
- Respiratory Medicine (871)
- Rheumatology (411)
- Sports Medicine (343)
- Surgery (451)
- Toxicology (53)
- Transplantation (185)
- Urology (166)